profit from every $100 of sales.
$0$100
Helen of Troy
$37.32+0.35% today
+95.7% in 1 year
1-year low $13.881-year high $38.20
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2026.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Helen of Troy sold, what it kept, and what it did with the cash.
Sales went from $2.07 billion in 2023 to $1.79 billion in 2026, with -$899 million of profit last year.
SalesProfit
Helen of Troy handed back 1% of the cash it generated last year.
Buybacks $2M
Free cash flow 2026$132M
Bought back its own shares$2M
Paid as dividends–
Cash vs. debt$19M vs. $834M
Helen of Troy vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Helen of Troy | No profit yet | ||
 Procter & Gamble | 24.5× · Fair price | ||
 L'Oréal | 39.3× · Expensive | ||
 Unilever | 13.7× · Cheap | ||
 Colgate-Palmolive | 37.2× · Expensive |
AI analysis
An AI analyst reads Helen of Troy's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 2,073 | 2,005 | 1,908 | 1,786 | |
| 899 | 949 | 914 | 816 | |
| 239 | 279 | 209 | 107 | |
| 257 | 314 | 199 | -728 | |
| 143 | 169 | 124 | -899 | |
| 5.95 | 7.03 | 5.37 | -39.08 | |
| 43.4% | 47.3% | 47.9% | 45.7% | |
| 11.5% | 13.9% | 11.0% | 6.0% | |
| 6.9% | 8.4% | 6.5% | -50.3% |
Balance sheet
| In millions of USD | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Total assets | 2,914 | 2,839 | 3,132 | 2,116 |
| Cash | 29 | 19 | 19 | 19 |
| Total debt | 977 | 703 | 957 | 834 |
| Total liabilities | 1,425 | 1,201 | 1,449 | 1,317 |
| 1,489 | 1,637 | 1,683 | 798 | |
| 24 | 24 | 23 | 23 | |
| 6.8% | 8.8% | 4.3% | -37.8% | |
| 9.6% | 10.3% | 7.4% | -112.6% |
Cash flow
| In millions of USD | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 208 | 306 | 113 | 171 | |
| 175 | 37 | 30 | 39 | |
| 33 | 269 | 83 | 132 | |
| Dividends paid | – | – | – | – |
| 18 | 55 | 103 | 2 | |
| 27 | 34 | 21 | 17 |
Valuation
- –
- 10.6×
- –
- 0.7×
- 0.5×
- 6.6×
- –
- 15.1%
- -103.0%
- 0.0%
Profitability
- 45.7%
- 6.0%
- -50.3%
- -17.7%
- -43.0%
- -5.4%
- -94.5%
- -42.5%
- -43.6%
- –
Growth
- −4.8%
- –
- +58.7%
- –
- −1.5%
Financial health
- –
- 1.04
- 39.4%
- -12.2×
- 1.71
- 0.81
- 0.84
How it ranks in Consumer Staples
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 1%of 669
Bottom 28%of 672
Bottom 6%of 671
Top 10%of 666
What analysts expect
- Average price target
- $22.00
- Range
- $22.00 – $22.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 23, 2026 | 0.83 | 0.66 | +25.8% |
| Jan 8, 2026 | 1.71 | 1.71 | +0.0% |
| Oct 9, 2025 | 0.59 | 0.54 | +9.3% |
| Jul 10, 2025 | 0.41 | 0.91 | −54.9% |
| Apr 24, 2025 | 2.33 | 2.34 | −0.4% |
| Jan 8, 2025 | 2.67 | 2.61 | +2.3% |
| Oct 9, 2024 | 1.21 | 1.05 | +15.2% |
| Jul 9, 2024 | 0.99 | 1.59 | −37.7% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
38No pass
Benjamin Graham
58No pass
Philip Fisher
35No pass
Peter Lynch
19No pass
Joel Greenblatt
0No pass
Charlie Munger
23No pass
Terry Smith
20No pass
Questions about Helen of Troy
Is Helen of Troy a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Helen of Troy AI analysis
What does Helen of Troy do?
Helen of Troy Limited provides various consumer products in the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company operates through three segments: Home & Outdoor, Health & Wellness, and Beauty. It is in Household & Personal Products.
Does Helen of Troy pay a dividend?
No. Helen of Troy does not pay a dividend at the moment; in 2026 it returned $1.92 million to shareholders by buying back its own shares.
Is Helen of Troy stock halal?
No. Helen of Troy does not pass our halal screen: its debt is 96% of its market value, at or above the 33% limit. How we check
How has Helen of Troy stock done over the past year?
Up 95.7% over the past twelve months, to $37.32. It traded between $13.88 and $38.20 and is 2.3% below its high.
Who are Helen of Troy's competitors?
The largest listed companies in the same industry are Procter & Gamble, L'Oréal, Unilever and Colgate-Palmolive. The peers table on this page compares their profit, growth and price with Helen of Troy's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.